Actigraphy Activity Attentional fatigue Cancer Circadian rhythm Family caregiver Fatigue Radiation therapy Sleep Sleep disturbance Background: Little is known about the relationships between sleep/wake circadian activity rhythms and fatigue in family caregivers (FCs) of oncology patients.
objective measures of sleep disturbance. The amplitude of circadian activity rhythm was not related to any objective sleep measure but was correlated with self-report of longer sleep-onset latency. Conclusions: A significant percentage of FCs experience clinically meaningful disturbances in sleep-wake circadian activity rhythms. These disturbances occur primarily in sleep maintenance. Implications for Practice: Family caregivers need to be assessed, along with patients, for sleep disturbance, and appropriate interventions initiated for them and for the patient. A s noted by Berger 1 in her state-of-the-science article, ''patients with cancer and their caregivers often experience sleep-wake disturbances, particularly insomnia. However, this pervasive and distressing symptom is widely ignored.'' 1(pE165) Although the number of studies on sleep disturbance in oncology patients is increasing (for reviews, see References 1Y6), only a limited number of studies have evaluated for sleep disturbance in the family caregivers (FCs) of oncology patients. 7Y17
Descriptive Studies of Sleep Disturbance in FCs of Oncology Patients
In the first descriptive study of sleep disturbance in FCs of oncology patients with advanced cancer (n = 51), 12 95% of the FCs reported severe sleep problems measured using the Pittsburgh Sleep Quality Index (PSQI). In a subsequent analysis of interviews from the same sample, 7 FCs described severe fluctuations in sleep patterns over time. In a third article from this sample, 11 less functional coping, less mastery, higher levels of neuroticism, and higher levels of depression explained 41% of the variance in sleep disturbance.
Four additional studies 14Y17 have provided information on sleep disturbance in FCs of oncology patients. In a study of primarily female FCs (78%) of gastric cancer patients who were receiving chemotherapy in Korea (n = 103), 14 80% reported poor sleep quality using the PSQI. Poor sleep quality was moderately correlated with fatigue (r = 0.34, P G .01). In another study of the quality of sleep in primarily female FCs (53.3%) of Turkish cancer patients (n = 90), 17 72.2% reported poor sleep quality using the PSQI. The most commonly cited reasons for sleep disturbance were emotional distress, financial problems, and inadequate support systems.
In a third study of primarily male FCs (82.0%) of Taiwanese patients with breast cancer (n = 61), 15 54% reported poor sleep quality using the PSQI. In this study, poor sleep quality was associated with decreases in quality of life. In the most recent study, which used both subjective and objective measures of sleep disturbance, 16 58 FCs of patients with advanced cancer were assessed to determine the prevalence of sleep-wake disturbances, to monitor the amount of daytime spent in activity and rest, and to examine the relationships between sleep and other symptoms. Based on their self-reports, 41% of the FCs reported poor sleep quality. Based on the objective measure, 46% had a sleep efficiency index below the cutoff for clinically significant sleep disturbance. Poor sleep quality was associated with higher levels of anxiety.
In the only longitudinal study of sleep disturbance in FCs of oncology patients, 8 10 FCs were evaluated on a weekly basis using subjective and objective measures of sleep disturbance. A large amount of interindividual variability was found in FCs' levels of sleep disturbance over the 10 weeks of the study. Findings across these studies suggest that sleep disturbance is a common problem that affects between 40% and 90% of FCs of oncology patients. In addition, sleep disturbance is associated with increases in depressive symptoms, anxiety, and fatigue and has a negative impact on FCs' quality of life.
Fatigue in FCs of Oncology Patients
Findings from a recent review of symptoms in FCs of oncology patients 18 suggest that fatigue is a common problem in FCs. Although wide variability in fatigue severity was noted across studies, overall FCs reported moderate levels of fatigue. Whereas several studies found that sleep disturbance was associated with higher levels of fatigue in patients who underwent radiation therapy (RT), 19Y21 only 1 study found a similar relationship in FCs of oncology patients. 14 Given the growing number of FCs who provide care to oncology patients in the home 22, 23 and the paucity of published data, detailed information on sleep/wake and circadian activity rhythm parameters and their associations with fatigue in FCs is needed for comparative purposes in future studies. Therefore, the purposes of this study, in a sample of FCs of oncology patients who were about to start RT, were to describe values for nocturnal sleep/rest, daytime wake/activity, and circadian activity rhythm parameters measured using actigraphy and to evaluate the relationships between these objective parameters and subjective ratings of sleep disturbance and fatigue severity. It was hypothesized that a high percentage of FCs would report clinically meaningful levels of sleep disturbance and that significant correlations would be found between objective sleep/wake circadian activity rhythm parameters and subjective ratings of sleep disturbance and fatigue severity.
assumes the role of a caregiver, in most studies of symptoms in FCs, 26 the caregiver role is linked to the trajectory of the patient's treatment. Therefore, to obtain a ''baseline'' assessment of symptoms, FCs were recruited with the patients before the initiation of RT.
Patients and their FCs were recruited from RT departments in a Comprehensive Cancer Center and a community-based oncology program at the time of the patient's simulation visit. After recruitment of the patients, they were asked to identify the person most involved in their care (ie, their FC). If the FC was with the patient, the research nurse explained the study and obtained written informed consent from the FC. Family caregivers who were not with the patient were contacted by phone to determine their interest in study participation. The research nurse visited those FCs at home, obtained written informed consent, and had them complete the study questionnaires and begin wearing the wrist actigraph.
Family caregivers were eligible to participate if they were 18 years or older; were able to read, write, and understand English; gave written informed consent; had a Karnofsky Performance Status (KPS) score of 60 or greater; were living with the patient; and did not have a diagnosed sleep disorder (eg, sleep disordered breathing, narcolepsy, restless leg syndrome).
Theoretical Framework
The theoretical framework for the study was the Theory of Symptom Management (TSM), which was developed by faculty members in the Center for Symptom Management at the University of California, San Francisco. 27Y29 As it relates to this analysis, the symptom experience dimension includes an individual's perceptions of sleep disturbance, physical fatigue and energy, and attentional fatigue; an evaluation of the meaning of the symptoms; and response to the symptoms. The symptom management strategies dimension includes both the selfcare strategies that individuals use for themselves and the treatments that clinicians may prescribe. The outcomes dimension specifies that outcomes emerge from symptom management strategies as well as from the symptom experience. The TSM places the experience of symptom management within the context of the domains of nursing science, namely, person, health and illness, and environment. The focus of this analysis is on the symptom experience dimension of the TSM, specifically how the experiences of sleep disturbance, physical fatigue and energy, and attentional fatigue are related to each other in a sample of FCs of oncology patients at the initiation of RT.
Instruments
The study instruments included a demographic questionnaire, the KPS scale, 30 the PSQI, 31 the General Sleep Disturbance Scale (GSDS), 32 the Lee Fatigue Scale (LFS), 33 and the Attentional Function Index (AFI). 34 Objective data on sleep-wake circadian activity rhythms were obtained by continuous noninvasive monitoring of activity over 48 hours using a wrist motion sensor (Mini Motionlogger Actigraph; Ambulatory Monitoring Inc, Ardsley, New York). 35Y37 The demographic questionnaire obtained information on age, sex, marital status, education, ethnicity, employment status, living arrangements, the presence of a number of comorbid conditions, and the FC's relationship with the patient.
Subjective ratings of sleep disturbance were evaluated using the PSQI and the GSDS. The PSQI consists of 19 items designed to assess the quality of sleep in the past month. The global PSQI score is the sum of the 7 component scores (ie, subjective sleep quality, sleep latency, sleep duration, habitual sleep efficiency, sleep disturbances, use of sleeping medication, and daytime dysfunction). Each component score ranges from 0 to 3, and the global PSQI score ranges from 0 to 21. Higher global and component scores indicate more severe complaints and a higher level of sleep disturbance. A global PSQI score of greater than 5 indicates a significant level of sleep disturbance. 31 The PSQI has established internal consistency, test-retest reliability, and construct validity. 31, 38, 39 In this study, the Cronbach ! for the global PSQI score was .68.
The GSDS consists of 21 items designed to assess the quality of sleep in the past week. Each item is rated on a 0 (never) to 7 (everyday) numeric rating scale (NRS). The GSDS total score is the sum of the 7 subscale scores (ie, quality of sleep, quantity of sleep, sleep-onset latency, midsleep awakenings, early awakenings, medications for sleep, and excessive daytime sleepiness) that can range from 0 (no disturbance) to 147 (extreme sleep disturbance). Each mean subscale score can range from 0 to 7. Because the GSDS items are rated on a scale of 0 (never) to 7 (every day), the subscale scores provide an estimation of the number of days per week that a patient experiences a particular problem. Higher total and subscale scores indicate higher levels of sleep disturbance. Mean subscale scores of 3 or greater and a GSDS total score of 43 or greater indicate a significant level of sleep disturbance. 40 The GSDS has well-established validity and reliability in shift workers, pregnant women, and patients with cancer and HIV. 19, 32, 41 In the current study, the Cronbach ! for the GSDS total score was .79.
Subjective ratings of physical fatigue and energy were evaluated using the LFS. 33 The LFS consists of 18 items that are each rated on a 0-to 10-point NRS. Total fatigue and energy scores were calculated as the mean of the 13 fatigue items and the 5 energy items, with higher scores indicating greater fatigue severity and higher levels of energy. Respondents were asked to rate each item based on how they felt ''right now,'' within 30 minutes of awakening (ie, morning fatigue, morning energy), and prior to going to bed (ie, evening fatigue, evening energy). The LFS was used with healthy individuals 33, 42 and in patients with cancer and HIV. 19, 25, 43, 44 Cutoff scores of 3.2 or greater and 5.6 or greater indicate high levels of morning and evening fatigue, respectively. 40 Cutoff scores of 6.0 or less and 3.5 or less indicate low levels of morning and evening energy, respectively. The LFS was chosen for this study because it is relatively short and easy to administer and has well-established validity and reliability. In this study, Cronbach !'s for evening and morning fatigue at baseline were .95 and .96, respectively. Cronbach !'s for evening and morning energy were .95 and .96, respectively.
Subjective ratings of attentional fatigue were evaluated using the AFI. The AFI consists of 16 items that are each rated on a 0-to 10-point NRS. A mean AFI score was calculated, with higher scores indicating greater capacity to direct attention and therefore lower levels of attentional fatigue. 34 Based on a previously conducted analysis of the frequency distributions of AFI scores, attentional fatigue can be grouped into categories of functional status (ie, patients who score G5.0 functioning poorly and experiencing high levels of attentional fatigue, patients who score 5.0Y7.5 functioning moderately well and experiencing moderate levels of attentional fatigue, patients who score 97.5 functioning well and experiencing low levels of attentional fatigue). 45 The AFI has established reliability and validity. 34, 46 In the current study, Cronbach ! for the AFI was .95.
Objective data on sleep-wake circadian activity rhythm parameters were obtained by continuous noninvasive monitoring of activity over 48 hours using wrist actigraphy. Seven nocturnal sleep/rest, 4 daytime wake/activity, and 6 circadian activity rhythm parameters were selected from those identified by a National Cancer InstituteYsponsored conference, 3 an expert panel that recommended a standard set of research assessments in insomnia, 47 and recently published studies. 48, 49 Wrist actigraphy was validated with electroencephalographic measures of sleep and awakenings in men and women with both healthy and disturbed sleep patterns. 36, 37, 47 It provides continuous motion data using a battery-operated wristwatch-size microprocessor that senses motion with a piezoelectric beam and detects movement in all 3 axes. The accompanying Action 4 software (Ambulatory Monitoring Inc) allows analysis of activity and nonactivity as well as automatic scoring of sleep and wake episodes in minutes. Actigraphy scores, calculated using specific algorithms, correlate with polysomnography in adults at greater than 90%. 37 
Study Procedures
After written informed consent was obtained, FCs completed the demographic questionnaire, KPS scale, 30 PSQI, 31 GSDS, 32 and AFI. 34 Family caregivers were taught to complete the LFS 33 before going to bed each night (ie, evening fatigue, evening energy) and upon arising each morning (ie, morning fatigue, morning energy) for 2 consecutive days.
Family caregivers wore the wrist actigraph to monitor nocturnal sleep/rest and daytime wake/activity continuously for 2 consecutive weekdays and completed the 2-day diary. Family caregivers and patients wore the wrist actigraph on the same days prior to the initiation of RT. Family caregivers were asked to use the event marker on the wrist actigraph to indicate ''lights out'' and ''lights on'' time. Family caregivers reported no difficulties wearing the wrist actigraph. Because the actual time is important in the calculation of the amount of sleep obtained in the amount of time designated for sleep, having an additional source of information about nap times, bed times, and wake times is important. This information was recorded in a 2-day diary. Upon awakening, the FCs used the diary to indicate the number of awakenings during the night. Family caregivers returned the questionnaires and actigraphs to the research nurse in the RT department.
Data Analysis
Data were analyzed using SPSS version 18. 50 Descriptive statistics and frequency distributions were generated for the sample characteristics and symptom data. Spearman rank correlations were calculated between variables because of the ordinal nature of many of the variables.
Actigraphy files programmed in zero-crossing mode with 30-second intervals were analyzed using the Cole-Kripke algorithm in the Action 4 software (Ambulatory Monitoring Inc) by 2 of the researchers (K.L. and C.W.). First, the file was scanned for missing data. Time limits were set for the 48-hour period. The file was reviewed, and intervals were individually set for each day and night period using, in order of priority as decision guides: the event marker, diary data, channel data, and cascading movement data.
Because a minimum of 36 hours of continuous data is necessary to have sufficient data to calculate circadian rhythm parameters for a 24-hour period, 51 if more than 4 hours of day data or 2 hours of night data were missing, that day's or night's data were not used in the analyses. Cosinor analysis fit a cosine and sine wave to the wrist actigraphy data using a least-squares regression model. The mesor (24-hour adjusted mean value or y-intercept), amplitude, and acrophase (time of day for peak activity) were the circadian activity rhythm parameters obtained from the regression model. 52 The autocorrelation coefficient for a 24-hour rhythm was obtained from the Action 4 software program.
All calculations used actual values. Adjustments were not made for missing data. Therefore, the cohort for each analysis was dependent on the largest set of available data across groups. P G .05 was considered statistically significant.
n Results
Demographic and Clinical Characteristics
As summarized in Table 1 , the majority of the FCs (n = 103) were female (71.6%), white (78.4%), married/partnered (92.2%), and well educated, with a mean age of 61.7 (SD, 10.4) years. Family caregivers reported an average of 4.2 (SD, 2.9) comorbidities. The patients had prostate (59.2%), breast (26.2%), lung (7.8%), or brain (6.8%) cancer.
Subjective Ratings of Sleep Disturbance
Subjective ratings of sleep over the past month using the PSQI are listed in Table 2 . The mean global PSQI score was 5.7, which is higher than the cutoff score of greater than 5. Fiftynine percent of the FCs had a global PSQI score of greater than 5.
Subjective ratings of sleep over the past week using the GSDS are listed in Table 2 . The mean total GSDS score was 39.1, which is slightly lower than the cutoff score of 43 or greater. However, 39% of the FCs had a total GSDS of 43 or greater. The GSDS subscale scores for quantity of sleep and midsleep
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Cancer Nursing TM , Vol. 35 Nocturnal Sleep/Rest, Daytime Wake/Activity, and Circadian Activity Rhythm Parameters Subjective Ratings of Fatigue and Energy Table 2 summarizes the data on morning and evening fatigue and energy scores, as well as on attentional fatigue. Although the mean morning and evening fatigue scores were below the cutoff values for clinically significant levels of fatigue, 29.7% and 31.7% of the FCs reported morning and evening fatigue scores above these cutoff values. In contrast, both morning and evening mean energy levels were below the cutoff scores, which indicated low levels of energy in these FCs. The majority of FCs (53.0%) reported moderate to high levels of attentional fatigue.
Correlations Between Subjective Ratings of Sleep Disturbance and Nocturnal Sleep/Rest, Daytime Wake/Activity, and Circadian Activity Rhythm Parameters Tables 4 and 5 summarize the significant correlations between PSQI and GSDS subscale and total scores and the various sleep/rest, wake/activity, and circadian activity rhythm parameters obtained with actigraphy. As shown in Table 4 , a limited number of significant correlations were found between the PSQI subscale score of sleep duration and total sleep time and sleep period time. In addition, a significant negative correlation was found between the use of sleep medications and the wake/activity parameters obtained using actigraphy. As shown in Table 5 , a significant correlation was found between the GSDS total score and sleep-onset latency.
Correlations Between Fatigue and Energy
Scores and Subjective Ratings of Sleep Disturbance and Nocturnal Sleep/Rest, Daytime Wake/Activity, and Circadian Activity Rhythm Parameters
As shown in Table 6 , significant positive correlations were found between the majority of the subscale and total scores for both the PSQI and the GSDS and FCs' ratings of morning and evening fatigue. In addition, significant negative correlations were found between the majority of the subscale and total scores for both the PSQI and the GSDS and FCs' ratings of morning energy and attentional fatigue (ie, indicating higher levels of attentional fatigue). Only 2 significant correlations were found between fatigue and energy scores and the objective sleep parameters.
n Discussion
This study is the first to provide detailed subjective and objective data on sleep-wake circadian activity rhythm parameters and fatigue in a sample of FCs of oncology patients prior to the initiation of the patient's RT. Based on these FCs' subjective responses to the PSQI and the GSDS, approximately 40% to 60% experienced clinically significant levels of sleep disturbance. This percentage is consistent with findings from 2 studies, 15, 16 but lower than findings from 3 studies of FCs of oncology patients. 12, 14, 17 Using an actigraphy-sleep efficiency cutoff of less than 80%, 3 29.5% of the FCs had a ''bad night's sleep.'' Both the subjective and objective data suggest that a significant percentage of these FCs experience clinically 55 only a limited number of significant correlations were found between the nocturnal sleep/rest, daytime wake/activity, and circadian activity rhythm parameters obtained with actigraphy and the subjective ratings of various aspects of sleep disturbance using the PSQI and the GSDS. As shown in Tables 4 and 5, the strength of most of these correlations was small. As noted in a recent review, 35 numerous methodological challenges exist with actigraphy that may affect the strength of the correlations between objective and subjective measures of sleep disturbance. Whereas the agreement between actigraphy and polysomnography is high in normal sleepers, 37, 56 it can be lower in persons with poor sleep quality 57 because these persons tend to lie in bed motionless but awake for long periods. In this situation, whereas actigraphy would overestimate sleep duration, FCs would report poor sleep quality and less sleep time. This disparity is confirmed in this study because using previously established cutoff scores for the subjective measures, approximately 40% to 60% of the FCs had significant sleep disturbance at the initiation of RT. However, using a sleep efficiency cutoff of less than 80% for actigraphy, only 29.5% of the FCs were classified as having a significant level of sleep disturbance. In addition, in this study, the FCs' sleep period time ranged from 294 to 669 minutes (ie, 5Y11 hours), and based on the actigraphy data, more than 55% of FCs spent more than 8 hours in bed each night.
In several studies, 35, 48, 54, 55 recommendations were made to use both subjective and objective measures to evaluate sleep because these different approaches capture different aspects of disturbed sleep. For example, subjective measures capture the physical and mental aspects of sleep and the impact of sleep on an individual's ability to function. The use of multiple measures to evaluate sleep disturbance in FCs warrants investigation in future studies, particularly in terms of which measures are most sensitive to changes in various sleep parameters over time. This information is critical to the evaluation of the efficacy of pharmacological and nonpharmacological interventions to reduce sleep disturbance in FCs.
The PSQI was the most frequently used self-report measure to assess sleep quality in previous studies of FCs of oncology patients 12, 14, 17 and in FCs of patients with Alzheimer's disease, 58 dementia, 59 and Parkinson's disease. 60 The PSQI global score for this sample (5.7 [SD, 3.2]) was higher than values reported for control subjects (range, 1.9Y3.1), 31, 61 comparable to some studies of FCs of patients with cancer 14 and Parkinson's disease 60 (range, 5.5Y5.8), but lower than those in the studies of FCs of patients with advanced cancer (11.3), 12 dementia, 59 or advanced Alzheimer's disease 58 (range, 9.1Y10.4) . Differences among these studies, in the various PSQI subscale scores, followed a similar pattern. Of note, based on the PSQI data, more than 24% of the FCs in this study had problems with the initiation (sleep latency subscale), and 21% had problems with maintenance (sleep duration subscale) of sleep on 2 to 3 nights per week.
This study is the first to report data on subjective sleep disturbance using the GSDS in FCs of oncology patients. Using this scale, approximately 40% of the sample reported clinically significant levels of sleep disturbance. Similar to the PSQI, 19.8% of the FCs had a problem with the initiation of sleep (ie, sleep-onset latency). However, a higher percentage of FCs (ie, 37.1% [early awakenings] to 67.7% [midsleep awakenings]) reported problems with sleep maintenance. To put the total GDSD score of the FCs in this study into context (ie, 39.1 [SD, 16 .0]), these FCs had lower scores than patients with a variety Autocorrelation (comparison of the regularity and consistency of the rhythm from one day to the next day)
Range, j1 to +1; optimal = 1 0.45 0.14 0.09Y0.81
Abbreviation: TST, total sleep time.
of cancer diagnoses (ie, 54.7 and 52.1). 44, 62 However, FCs in this study had GSDS total scores comparable to mothers in their third trimester of pregnancy (43.9) 42 and women before and after hysterectomy (42.3 and 45.7), 63 but lower than nurses who worked nights (60.5) or rotated shifts (56.6) . 32 Because the GSDS items are rated on a scale of 0 (never) to 7 (everyday), the subscale scores provide an estimation of the number of days per week that FCs experienced a particular problem. As shown in Table 2 , 95% of the FCs in this study reported an insufficient amount of sleep on 4 or more days per week. In addition, almost 68% of the FCs experienced a clinically significant number of midsleep awakenings on almost 4 nights per week. Actigraphy data showed that FCs averaged 17.6 brief awakenings per night, which is well above healthy adult values of 2 to 6 times per night. 3 This high number of midsleep awakenings may be related to the fact that most FCs in this study were the spouses of patients with prostate cancer who awakened multiple times during the night to urinate. Taken together, data from the PSQI and the GSDS suggest that FCs in this study had problems with the maintenance of sleep.
Compared with healthy adult values, 49 all of the nocturnal sleep/rest actigraphy parameters, except sleep-onset latency, were outside the reference ranges. When these FCs' actigraphy data were compared with previous studies of FCs of patients with advanced cancer, 8, 16 sleep-onset latency was shorter in this study (12. 97 minutes) compared with that of Carter's study 8 (40. 0Y45.0 minutes). In addition, total sleep time was longer in this study (406.5 minutes) compared with that in Carter's study (290Y332 minutes). However, sleep efficiency (84%) was similar to that of Carter's study (73%Y80%), but worse than that in the study by Gibbins et al 16 (90%Y92%) . The number of awakenings identified in this study using actigraphy (17.6) was significantly higher than that reported in studies of FCs of patients with Alzheimer's disease (6.5) 64 or dementia (4.1). 59 Additional studies need to evaluate for differences in sleep-wake parameters in FCs of oncology patients at different points in the patient's disease and treatment trajectory.
Only 2 studies were found that reported on daytime wake/ activity in FCs. In a study of FCs of patients with advanced cancer, 16 based on actigraphy data, these FCs were inactive for 29% to 32% of the day and took 7 to 10 naps per day of approximately 8 to 10 minutes' duration. In a study of FCs of patients with Alzheimer's disease, 64 these FCs slept approximately 30 minutes per day, which is slightly less than was found in the current study (43 min/d). The percentage of time asleep per day in the current study (6%) was relatively low and is supported by the relatively small percentage of FCs who reported significant daytime dysfunction using both the PSQI (6.0%) and the GSDS (14.9%). This finding may be partially explained by the relatively high percentage of FCs (47.5%) who were employed. Additional research is warranted on when and how often FCs of oncology patients take naps, as well as the duration of naps, because findings from several studies suggest 
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Cancer Nursing TM , Vol. 35, No. 1, 2012 n 77 that ''power naps'' (ie, naps of G30 minutes' duration that occur at around 3:00 PM) improve an individual's ability to function throughout the rest of the day. 65 Although findings from several studies of primarily patients with breast cancer 48,49,66Y70 suggest that circadian rhythm parameters are significantly disrupted in oncology patients, no studies were found that evaluated circadian activity rhythm parameters in FCs of oncology patients. In this study, acrophase values were similar to the general population. However, all of the other circadian rhythm parameters were below healthy adult values. 49 This finding suggests that these FCs had dampened circadian rhythms with low daytime activity and higher nighttime activity. However, because circadian rhythm data were collected for only 36 hours, additional research is warranted to confirm the findings from this study.
Family caregivers in this study reported moderate levels of morning and evening fatigue. In addition, approximately 50% reported moderate levels of attentional fatigue. An important finding is that more than 35% of the FCs in this study reported low levels of morning and evening energy. As expected, increased levels of morning fatigue, as well as attentional fatigue, and decreased levels of morning energy were associated with the majority of the subscale and total scores on the PSQI and the GSDS. However, fatigue and energy scores were not correlated with the majority of the actigraphy measures.
A number of study limitations need to be acknowledged. The sample was primarily female, white, and well educated, with a mean age of 62 years. Therefore, these findings may not generalize to all FCs of patients with cancer. Although the sample size was relatively small, this study provides important information on sleep-wake circadian activity rhythm parameters that can be used for comparative purposes. Ideally, actigraphy data should be collected for longer periods to study circadian rhythms. However, data were collected only on weekdays, which eliminated changes in the various objective parameters that might occur on weekends. Therefore, these results should be interpreted with caution and not generalized to both weekdays and weekends. Finally, data were not available on the specific sleep medications that these FCs used or on other medications that could contribute to sleep disturbance.
Despite these limitations, findings from this study suggest that a significant percentage of FCs of oncology patients experience clinically meaningful disturbances in sleep-wake circadian activity rhythms. Additional research is warranted on how both subjective and objective parameters change over time, on which FCs are at greatest risk for these disturbances, on what factors contribute to sleep disturbance in these FCs, and on the efficacy of various pharmacological and nonpharmacological interventions to decrease the levels of disturbance in these FCs. In addition, the relationships between changes in patients' and FCs' subjective and objective sleep disturbance parameters need to be evaluated during and following the patients' cancer treatment.
As noted in a number of reviews, 1,4,5 clinicians need to perform systematic assessments of FCs' sleep quality. These sleep assessments should focus on difficulty falling asleep and staying asleep and excessive daytime sleepiness. In addition, the impact of sleep disturbance on FCs' ability to function needs to be assessed. Oncology clinicians need to assist FCs and patients to follow basic sleep hygiene principles. For example, FCs and patients should be encouraged to establish regular sleep and wake times and to engage in regular exercise. Family caregivers and patients need to be reminded to avoid excessive fluid intake and restrict the consumption of caffeinated beverages in the evening. 1 Implementation of these simple measures may improve FCs' and patients' sleep quality during and after cancer treatment. 
